Shoham Moshe 4
4 · Microbot Medical Inc. · Filed Sep 25, 2017
Insider Transaction Report
Form 4
Shoham Moshe
Director
Transactions
- Sale
Common Stock
2017-09-15$1.25/sh−74,975$93,719→ 1,592,090 total - Sale
Common Stock
2017-09-15$1.27/sh−27,384$34,778→ 1,592,090 total - Sale
Common Stock
2017-09-15$1.28/sh−14,400$18,432→ 1,592,090 total - Sale
Common Stock
2017-09-15$1.30/sh−1,471$1,920→ 1,592,090 total - Sale
Common Stock
2017-09-15$1.32/sh−200$264→ 1,592,090 total - Sale
Common Stock
2017-09-15$1.25/sh−28,657$35,965→ 1,592,090 total - Sale
Common Stock
2017-09-15$1.26/sh−40,500$51,030→ 1,592,090 total - Sale
Common Stock
2017-09-15$1.28/sh−11,083$14,242→ 1,592,090 total - Sale
Common Stock
2017-09-15$1.29/sh−9,001$11,656→ 1,592,090 total - Sale
Common Stock
2017-09-15$1.27/sh−400$507→ 1,592,090 total - Sale
Common Stock
2017-09-15$1.27/sh−1,200$1,530→ 1,592,090 total - Sale
Common Stock
2017-09-15$1.29/sh−6,463$8,337→ 1,592,090 total - Sale
Common Stock
2017-09-15$1.31/sh−7,490$9,812→ 1,592,090 total - Sale
Common Stock
2017-09-15$1.26/sh−20,276$25,649→ 1,592,090 total - Sale
Common Stock
2017-09-15$1.30/sh−6,500$8,450→ 1,592,090 total
Footnotes (1)
- [F1]Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions.